Carregant...

Brain Injury Biomarkers Are Not Dependent on β-amyloid in Normal Elderly

BACKGROUND: The new criteria for preclinical Alzheimer’s Disease (AD) proposed 3 stages: abnormal levels of β-amyloid (stage 1); stage 1 plus evidence of brain injury (stage 2); and stage 2 plus subtle cognitive changes (stage 3). However, a large group of subjects with normal β-amyloid biomarkers h...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Knopman, David S., Jack, Clifford R., Wiste, Heather J., Weigand, Stephen D., Vemuri, Prashanthi, Lowe, Val J., Kantarci, Kejal, Gunter, Jeffrey L., Senjem, Matthew L., Mielke, Michelle M., Roberts, Rosebud O., Boeve, Bradley F., Petersen, Ronald C.
Format: Artigo
Idioma:Inglês
Publicat: 2013
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3660408/
https://ncbi.nlm.nih.gov/pubmed/23424032
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ana.23816
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!